Norrie Disease and Exudative Vitreoretinopathy in Families with Affected Female Carriers

Abstract

Purpose

Norrie disease (ND) is a rare X-linked recessive disorder characterized by congenital blindness, which is often associated with sensorineural hearing loss and mental retardation. X-linked familial exudative vitreoretinopathy (FEVR) is a hereditary disorder characterized by an abnormality of the peripheral retina and is not associated with systemic diseases. X-linked recessive disorders generally do not affect females. Here we show that female carriers can be associated with manifestation of an X-linked disorder.

Methods

A four-generation family with an affected female, and a history of congenital blindness and hearing loss, was identified through the pro-band. A second family, with a full-term female infant, was evaluated through ophthalmic examinations and found to exhibit ocular features, such as retinal folds, retinal detachment and peripheral exudates. Peripheral blood specimens were collected from several affected and unaffected family members. DNA was extracted and analyzed by single-strand conformation polymorphism (SS-CP) following polymerase chain reaction (PCR) amplification of the exons of the Norrie disease gene. The amplified products were sequenced by the dideoxy chain termination method.

Results

In an X-linked four-generation family, a novel missense (A118D) mutation in the third exon of the Norrie disease gene, was identified. The mutation was transmitted through three generations and cosegregated with the disease. The affected maternal grandmother and the unaffected mother carried the same mutation in one of their alleles. In an unrelated sporadic family, a heterozygous missense mutation (C96Y) was identified in the third exon of the Norrie disease gene in an affected individual. Analysis of exon-1 and 2 of the Norrie disease gene did not reveal any additional sequence alterations in these families. The mutations were not detected in the unaffected family members and the 116 normal unrelated controls, suggesting that they are likely to be the pathogenic mutations.

Conclusions

The results further strengthen the proposal that X-linked disorders can occur in female carriers, due likely to an unfavorable X-inactivation.

Keywords

Heterozygous Norrie disease Mutation Recessive Vitreoretinopathy Sporadic

Get full access to this article

View all access options for this article.

References

Warburg

. Norrie disease. Birth defects. 1971; 7: 117–4.

Warburg

. Norrie disease: Differential diagnosis and treatment. Acta Ophthalmol 1975; 53: 217–36.

Holmes

L.B.

. Norrie disease: An X-linked syndrome and retinal malformation, mental retardation and deafness. J Pediatr 1971, 79: 89–92.

Enyedi

L.B.

, Juan

. Ultrastructural study of Norrie disease. Am J Ophthalmol 1991, 111: 439–5.

Joos

K.M.

, Kimura

A.E.

, Vandenburg

. et al. Ocular findings associated with a Cys 39 Arg mutation in the Norrie disease gene. Arch Ophthalmol 1994; 112: 1574–9.

Ohba

, Yamashita

. Primary vitreoretinal dysplasia resembling Norrie disease in a female: association with X-autosome chromosomal translocation. Br J Ophthalmol 1986; 70: 64–71.

Chen

Z-Y

, Batinelli

E.M.

, Woodruff

Characterization of a mutation within the NDP gene in a family with a manifesting female carrier.

Hum Mol Genet 1993; 2: 1727–9.

Sims

K.B.

, Irvine

A.R.

, Good

W.V.

. Norrie disease in a family with a manifesting female carrier. Arch Ophthalmol 1997; 115: 517–9.

Criswick

V.G.

, Schepens

C.L.

. Familial exudative vitreoretinopathy. Am J Ophthalmol 1969; 68: 578–94.

10.

Van Nollhuys

C.E.

. Dominant exudative vitreoretinopathy. Ophthal Pediatr Genet 1985; 5: 31–8.

11.

Gow

, Oliver

G.L.

. Familial exudative vitreoretinopathy. An expanded view. Arch Ophthalmol 1971; 86: 150–5.

12.

Shastly

B.S.

, Trese

M.T.

. Familial exudative vitreoretinopathy. Further evidence for genetic heterogeneity. Am J Med Genet 1997; 69: 217–8.

13.

Plager

D.A.

, Orgel

I.K.

, Ellis

F.D.

X-linked recessive familial exudative vitreoretinopathy.

Am J Ophthalmol 1992; 114: 145–8.

14.

Chen

Z.Y.

, Battinelli

, Fielder

A mutation in the Norrie disease gene associated with X-linked familial exudative vitreoretinopathy.

Nat Genet 1993; 5: 180–3.

15.

Shastry

B.S.

, Hejtmancik

J.F.

, Plager

D.A.

Linkage and candidate gene analysis of X-linked familial exudative vitreoretinopathy.

Genomics 1995; 27: 341–4.

16.

Shastry

B.S.

, Hejtmancik

J.F.

, Trese

M.T.

. Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy. Hum Mutat 1997; 9: 396–401.

17.

Fuchs

, Kellner

, Wedemann

Missense mutation in the Norrie disease gene associated with X-linked exudative vitreoretinopathy.

Hum Mutat 1995, 6: 257–9.

18.

Shastry

B.S.

, Liu

, Hejtmancik

J.F.

Evidence for genetic heterogeneity in X-linked familial exudative vitreoretinopathy.

Genomics 1997; 44: 247–8.

19.

Wengler

G.S.

, Parolini

, Fiorini

A PCR based non-radioactive X-chromosome inactivation assay for genetic counseling in X-linked primary immunodeficiencies.

Life Sci 1997; 61: 1405–11.

20.

Meitinger

, Meindl

, Bork

Molecular modeling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure.

Nat Genet 1993; 5: 376–80.

21.

Meindl

, Berger

, Meitinger

Norrie disease is caused by mutations in the extracellular protein resembling C-terminal globular domain of mucins.

Nat Genet 1992; 2: 139–43.

22.

Parolini

, Ressmann

, Haas

O.A.

X-linked Wisskott -Aldrich syndrome in a girl.

N Engl J Med 1998; 338: 291–5.

23.

Puck

J.M.

, Willard

H.F.

. X-inactivation in females with X-linked diseases. N Engl J Med 1998; 338: 325–8.

24.

Mintz-Hittner

H.A.

, Ferrell

R.E.

, Sims

K.B.

Peripheral retinopathy in offspring of carriers of Norrie disease gene mutations.

Ophthalmology 1996; 103: 2128–34.